BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17167730)

  • 1. [Psychometric properties of a German version of the Apathy Evaluation Scale].
    Lueken U; Seidl U; Schwarz M; Völker L; Naumann D; Mattes K; Schröder J; Schweiger E
    Fortschr Neurol Psychiatr; 2006 Dec; 74(12):714-22. PubMed ID: 17167730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of a scale for assessing lack of motivation in elderly persons].
    Chantoin S; Hazif-Thomas C; Billon R; Thomas P
    Encephale; 2001; 27(5):450-8. PubMed ID: 11760695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment.
    Robert PH; Clairet S; Benoit M; Koutaich J; Bertogliati C; Tible O; Caci H; Borg M; Brocker P; Bedoucha P
    Int J Geriatr Psychiatry; 2002 Dec; 17(12):1099-105. PubMed ID: 12461757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a short version of the Apathy Evaluation Scale specifically adapted for demented nursing home residents.
    Lueken U; Seidl U; Völker L; Schweiger E; Kruse A; Schröder J
    Am J Geriatr Psychiatry; 2007 May; 15(5):376-85. PubMed ID: 17463188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An informant-based assessment of apathy in Alzheimer disease.
    Strauss ME; Sperry SD
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Sep; 15(3):176-83. PubMed ID: 12218710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of demotivation and affective disorders in apathy in patients with Parkinson's disease without dementia and depression].
    Delgadillo-Iniguez D; Derouesné C; Lacomblez L; Gély-Nargeot MC
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Jun; 11(2):197-207. PubMed ID: 23803637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations.
    Leentjens AF; Dujardin K; Marsh L; Martinez-Martin P; Richard IH; Starkstein SE; Weintraub D; Sampaio C; Poewe W; Rascol O; Stebbins GT; Goetz CG
    Mov Disord; 2008 Oct; 23(14):2004-14. PubMed ID: 18709683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Lille Apathy Rating Scale: validation of a caregiver-based version.
    Dujardin K; Sockeel P; Delliaux M; Destée A; Defebvre L
    Mov Disord; 2008 Apr; 23(6):845-9. PubMed ID: 18307266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of the Temporal Experience of Pleasure Scale (TEPS) in a French-speaking environment].
    Favrod J; Ernst F; Giuliani F; Bonsack C
    Encephale; 2009 Jun; 35(3):241-8. PubMed ID: 19540410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer's disease.
    Hsieh CJ; Chu H; Cheng JJ; Shen WW; Lin CC
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):227-34. PubMed ID: 22443245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are there common core features of apathy in different neuropsychiatric samples as assessed by the Apathy Evaluation Scale?
    Sagen U; Faerden A; Haug T; Melle I; Finset A; Dammen T
    Nord J Psychiatry; 2010; 64(1):49-57. PubMed ID: 19883192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Brief measure to assess perception of self-influence on the disease course. Version for schizophrenia].
    Kokoszka A; Telichowska-Leśna A; Radzio R
    Psychiatr Pol; 2008; 42(4):503-13. PubMed ID: 19189595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
    Pedersen KF; Larsen JP; Alves G; Aarsland D
    Parkinsonism Relat Disord; 2009 May; 15(4):295-9. PubMed ID: 18801696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The German version of the Toronto Structured Interview for Alexithymia: factor structure, reliability, and concurrent validity in a psychiatric patient sample.
    Grabe HJ; Löbel S; Dittrich D; Bagby RM; Taylor GJ; Quilty LC; Spitzer C; Barnow S; Mathier F; Jenewein J; Freyberger HJ; Rufer M
    Compr Psychiatry; 2009; 50(5):424-30. PubMed ID: 19683612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Calgary Depression Rating Scale for schizophrenia in a healthy control group: psychometric properties and reference values.
    Müller MJ; Brening H; Gensch C; Klinga J; Kienzle B; Müller KM
    J Affect Disord; 2005 Sep; 88(1):69-74. PubMed ID: 16040126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease.
    Pedersen KF; Larsen JP; Aarsland D
    Parkinsonism Relat Disord; 2008; 14(3):183-6. PubMed ID: 17889589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The syndromal validity and nosological position of apathy in Parkinson's disease.
    Starkstein SE; Merello M; Jorge R; Brockman S; Bruce D; Power B
    Mov Disord; 2009 Jun; 24(8):1211-6. PubMed ID: 19412942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Psychometric evaluation of the German version of the 'Health of the Nation Outcome Scales, HoNOS-D': on the feasibility and reliability of clinician-performed measurements of severity in patients with mental disorders.
    Andreas S; Harfst T; Dirmaier J; Kawski S; Koch U; Schulz H
    Psychopathology; 2007; 40(2):116-25. PubMed ID: 17215598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.